We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord

Ticker
ACHL

Price
1.48
Stock movement up
+0.01 (0.68%)
Company name
Achilles Therapeutics PLC ADR
Exchange
(NASDAQ
,
Currency
USD
)
Sector
Healthcare >
Biotechnology
Market cap
60.81M
Ent value
-5.70M
Price/Sales
-
Price/Book
0.59
Div yield
-
Div growth
-
Growth years
-
FCF payout
-
Trailing P/E
-
Forward P/E
-
PEG
-
EPS growth
-
1 year return
34.55%
3 year return
-20.81%
5 year return
-
10 year return
-
Last updated: 2025-04-18

DIVIDENDS

ACHL does not pay dividends or no data was received

VALUATION

Valuation Ratios

Valuation Ratios data
Trailing P/E-
Price to OCF-
Price to FCF-
Price to EBITDA-
EV to EBITDA-

Valuation (Sales/Book Value)

Valuation (Sales/Book Value) data
Price to Sales-
Price to Book0.59
EV to Sales-

FINANCIALS

Per share

Per share data
Current share count41.09M
EPS (TTM)-1.65
FCF per share (TTM)-1.13

Income statement

Income statement data
Revenue (TTM)0.00
Gross profit (TTM)-2.36M
Operating income (TTM)-72.02M
Net income (TTM)-66.87M
EPS (TTM)-1.65
EPS (1y forward)-0.87

Margins

Margins data
Gross margin (TTM)-
Operating margin (TTM)-
Profit margin (TTM)-

Balance Sheet

Please create a free account or log in to access this chart
Balance Sheet data
Cash86.05M
Net receivables21.79M
Total current assets111.63M
Goodwill0.00
Intangible assets0.00
Property, plant and equipment0.00
Total assets122.68M
Accounts payable4.25M
Short/Current long term debt3.62M
Total current liabilities18.47M
Total liabilities19.54M
Shareholder's equity103.14M
Net tangible assets0.00

Cash flow

Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)-48.99M
Capital expenditures (TTM)740.64K
Free cash flow (TTM)-45.81M
Dividends paid (TTM)0.00

Financial returns

Please create a free account or log in to access this chart
Financial returns data
Return on Equity-64.84%
Return on Assets-54.51%
Return on Invested Capital-62.64%
Cash Return on Invested Capital-42.91%

STOCK INFORMATION

Stock chart

Stock price data
Open1.48
Daily high1.50
Daily low1.45
Daily Volume1.20M
All-time high17.86
1y analyst estimate6.00
Beta1.34
EPS (TTM)-1.65
Dividend per share-
Ex-div date-
Next earnings date6 May 2025

Downside potential

Downside potential data
ACHLS&P500
Current price drop from All-time high-91.71%-7.74%
Highest price drop-96.08%-56.47%
Date of highest drop11 Sep 20249 Mar 2009
Avg drop from high-83.86%-11.07%
Avg time to new high499 days12 days
Max time to new high995 days1805 days
COMPANY DETAILS
ACHL (Achilles Therapeutics PLC ADR) company logo
Marketcap
60.81M
Marketcap category
Small-cap
Description
Achilles Therapeutics plc, a biopharmaceutical company, develops precision T cell therapies to treat solid tumors. Its platform identifies mutations formed early in the development of cancer. The company offers PELEUS, a proprietary AI-powered bioinformatics platform, used to identify clonal neoantigens in a patient. It also develops CHIRON, which is in Phase I/IIa clinical trial for use in the treatment of advanced non-small cell lung cancer; and THETIS, a product candidate in Phase I/IIa clinical trial for use in the treatment of metastatic or recurrent melanoma. The company was formerly known as Achilles TX Limited and changed its name to Achilles Therapeutics Plc in February 2021. Achilles Therapeutics Plc was founded in 2016 and is headquartered in London, the United Kingdom.
Employees
204
Website
https://www.achillestx.com
Investor relations
-
SEC filings
ACHL SEC filings
CEO
Country
USA
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
UNDERSTAND THE BUSINESS
COMPANY NEWS
Seeking AlphaPress releases
No items found
iO Charts is a Seeking Alpha partner
Disclaimer
Skyfall Technology OÜ assumes no responsibility or liability for any errors or omissions in the content of this site. The information contained in this site is provided on an “as is” basis with no guarantees of completeness, accuracy, usefulness or timeliness. Please also note, that any action you take upon the information provided on this website is strictly at your own risk. This website is intended to be used and must be used for informational purposes only and you should take independent financial advice from a professional and independently research and verify everything you see on the site.
Menu
HomePortfolio ManagementCompany ScreenerGreen InvestmentExchangesContact Us
Language
ENHUNOSVDAFIESDENLFRITPTPLCSSKROELTRRUAF
© 2024 Skyfall Technology OÜ All Rights Reserved